Conclusion
The study confirms propranolol’s effectiveness and safety, reinforcing
the need for early intervention and close monitoring following treatment
termination to prevent regrowth. Ultimately, this research contributes
to advancing the understanding and treatment of IH, aiming to optimize
patient outcomes and reduce morbidity.
Key words: Infantile hemangioma, Vascular anomalies, Vascular
malformation, Propranolol, B-blockers